Gycabiane and Glycemic Control of Prediabetic Subjects

PiLeJe

Status: Completed

Conditions: Hyperglycemia

Treatments: Dietary Supplement: Glycabiane; Dietary Supplement: placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT01530685

PILEJE-Glyca-0910

Details and patient eligibility

About

The purpose of this study is to examine the effects of supplementation Glycabiane, a dietary supplement, on glycemic control of overweight prediabetic subjects.

Full description

Cinnamon's effects on blood glucose have been the subject of many clinical and animal studies; however, the issue of cinnamon intake's effect on fasting blood glucose (FBG) in people with prediabetes still remains unclear.

The main purpose of this study is to examine the effects of supplementation with Glycabiane, a dietary supplement rich in cinnamon extract, on fast blood glucose of overweight prediabetic subjects in a randomized, placebo-controlled, clinical trial.

Enrollment: 83 patients

Sex: All

Ages: 25 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male or female from 25 to 65 years old
• 1.0g/L ≤ fast blood glucose < 1.26g/L
• overweight (IMC > 25)

Exclusion criteria

• thyroid disease
• hypogonadism
• History of musculoskeletal, autoimmune or neurological disease
• Treatment against thyroid disease, hypoglycemia, hypertension, or anti-coagulant
• Pregnant or lactating women

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

83 participants in 2 patient groups, including a placebo group

Glycabiane, gelule

Experimental group

Treatment:

Dietary Supplement: Glycabiane

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: placebo